pIGF1_P1 Promoter-FLuc2P
(Plasmid
#154261)
-
PurposeDestabilized firefly luciferase reporter containing the canonical Human IGF-1 P1 Promoter.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 154261 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGL4.15
-
Backbone manufacturerPromega
- Backbone size w/o insert (bp) 5969
- Total vector size (bp) 8048
-
Vector typeMammalian Expression
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameIGF-1 canonical P1 Promoter
-
Alt nameInsulin-like Growth Factor 1
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2079
-
GenBank IDGene ID: 3479
-
Entrez GeneIGF1 (a.k.a. IGF, IGF-I, IGFI, MGF)
- Promoter Human IGF-1 P1 Promoter
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BglII (not destroyed)
- 3′ cloning site HindIII (not destroyed)
- 5′ sequencing primer RVprimer3 (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pIGF1_P1 Promoter-FLuc2P was a gift from Antonio Amelio (Addgene plasmid # 154261 ; http://n2t.net/addgene:154261 ; RRID:Addgene_154261) -
For your References section:
CRTC1/MAML2 directs a PGC-1alpha-IGF-1 circuit that confers vulnerability to PPARgamma inhibition. Musicant AM, Parag-Sharma K, Gong W, Sengupta M, Chatterjee A, Henry EC, Tsai YH, Hayward MC, Sheth S, Betancourt R, Hackman TG, Padilla RJ, Parker JS, Giudice J, Flaveny CA, Hayes DN, Amelio AL. Cell Rep. 2021 Feb 23;34(8):108768. doi: 10.1016/j.celrep.2021.108768. 10.1016/j.celrep.2021.108768 PubMed 33626346